We are live on ! Find out more
AIM

Assured Investment Management Portfolio holdings

AUM $79.5M
1-Year Est. Return 115.55%
This Fund
S&P 500
This Quarter Est. Return
-18.95%
1 Year Est. Return
+115.55%
3 Year Est. Return
+18.27%
5 Year Est. Return
+44.63%
10 Year Est. Return
AUM
$3.53B
AUM Growth
-$1.98B
Cap. Flow
-$1.16B
Cap. Flow %
-32.76%
Top 10 Hldgs %
27.64%
Holding
1,448
New
304
Increased
386
Reduced
403
Closed
343

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.11%
2 Healthcare 10.65%
3 Technology 10%
4 Industrials 9.59%
5 Energy 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNTR
1026
DELISTED
Venator Materials PLC
VNTR
$63K ﹤0.01%
14,947
-4,099
-22% -$26.5K
NXEO
1027
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$63K ﹤0.01%
+7,291
New +$73.6K
AYR
1028
DELISTED
Aircastle Ltd
AYR
$61K ﹤0.01%
3,539
-15,551
-81% -$296K
ABCB icon
1029
Ameris Bancorp
ABCB
$5.88B
$60K ﹤0.01%
1,880
-359
-16% -$14.6K
PJT icon
1030
PJT Partners
PJT
$4.33B
$59K ﹤0.01%
1,518
-1,365
-47% -$61.2K
BPMC
1031
DELISTED
Blueprint Medicines
BPMC
$57K ﹤0.01%
1,059
-734
-41% -$44.6K
INGN icon
1032
Inogen
INGN
$163M
$57K ﹤0.01%
456
-5,310
-92% -$874K
INO icon
1033
Inovio Pharmaceuticals
INO
$76.1M
$57K ﹤0.01%
1,189
+744
+167% +$45.2K
ARNA
1034
DELISTED
Arena Pharmaceuticals Inc
ARNA
$57K ﹤0.01%
+1,463
New +$57.4K
ADVM
1035
DELISTED
Adverum Biotechnologies
ADVM
$54K ﹤0.01%
+1,723
New +$70.1K
DESP
1036
DELISTED
Despegar.com
DESP
$54K ﹤0.01%
+4,370
New +$66K
RETA
1037
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$53K ﹤0.01%
+942
New +$57.5K
PBYI icon
1038
Puma Biotechnology
PBYI
$442M
$50K ﹤0.01%
+2,442
New +$73.3K
PTC icon
1039
PTC
PTC
$16.4B
$49K ﹤0.01%
+597
New +$52.4K
CISN
1040
DELISTED
Cision Ltd. Ordinary Share
CISN
$49K ﹤0.01%
+4,176
New +$57.1K
RGNX icon
1041
Regenxbio
RGNX
$688M
$46K ﹤0.01%
1,107
+195
+21% +$11.4K
CMPR icon
1042
Cimpress
CMPR
$2.29B
$45K ﹤0.01%
439
+319
+266% +$37K
SFL icon
1043
SFL Corp
SFL
$1.58B
$44K ﹤0.01%
4,134
-52,132
-93% -$653K
ATTU
1044
DELISTED
Attunity Ltd
ATTU
$44K ﹤0.01%
+2,226
New +$42.2K
APLS
1045
DELISTED
Apellis Pharmaceuticals
APLS
$43K ﹤0.01%
+3,266
New +$50.1K
CAI
1046
DELISTED
CAI International, Inc.
CAI
$42K ﹤0.01%
+1,819
New +$41.4K
HURN icon
1047
Huron Consulting
HURN
$2.42B
$41K ﹤0.01%
799
-2,383
-75% -$121K
CASH icon
1048
Pathward Financial
CASH
$1.81B
$40K ﹤0.01%
2,051
-24,814
-92% -$579K
EME icon
1049
Emcor
EME
$35.7B
$40K ﹤0.01%
668
-12,075
-95% -$836K
FHI icon
1050
Federated Hermes
FHI
$4.71B
$40K ﹤0.01%
+1,497
New +$37.2K

Similar funds

Assured Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Assured Investment Management held 1,448 positions worth $3.53B, down 36% from $5.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Assured Investment Management withdrew a net $1.16B in Q4 2018, closing 343 positions and reducing 403 holdings. Its most notable exit was Ocean Rig UDW Inc. Class A Common Shares, an estimated $341M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Assured Investment Management opened a new position in Transocean worth $33.1M.

  • Assured Investment Management's largest Q4 2018 buy was Transocean: 4,771,460 shares worth $33.1M.
  • Assured Investment Management added most to PG&E in Q4 2018, an estimated $133M increase.
  • Assured Investment Management's biggest Q4 2018 reduction was Golar LNG, cutting an estimated $36.7M.
  • Assured Investment Management fully exited Ocean Rig UDW Inc. Class A Common Shares in Q4 2018, selling an estimated $341M.
  • Assured Investment Management's ten largest holdings make up 28% of its $3.53B portfolio in Q4 2018.
  • Assured Investment Management opened 304 new positions and closed 343 in Q4 2018.
  • Assured Investment Management's portfolio value fell 36% quarter-over-quarter to $3.53B.

Based on Assured Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.